Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
CRISPR Therapeutics AG (NASDAQ: CRSP) closed the day trading at $44.51 down -4.42% from the previous closing price of $46.57. In other words, the price has decreased by -$4.42 from its previous closing price. On the day, 2.15 million shares were traded.
Ratios:
For a better understanding of CRSP, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 22.07 and its Current Ratio is at 22.07. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Evercore ISI on February 14, 2025, Upgraded its rating to Outperform and sets its target price to $99 from $60 previously.
On February 12, 2025, TD Cowen Upgraded its rating to Hold which previously was Sell but kept the price unchanged to $35.
On February 03, 2025, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $65.H.C. Wainwright initiated its Buy rating on February 03, 2025, with a $65 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 19 ’25 when Kulkarni Samarth sold 18,360 shares for $55.20 per share. The transaction valued at 1,013,564 led to the insider holds 171,613 shares of the business.
Kulkarni Samarth sold 11,640 shares of CRSP for $640,782 on Feb 18 ’25. The Chief Executive Officer now owns 196,901 shares after completing the transaction at $55.05 per share. On Feb 19 ’25, another insider, Kulkarni Samarth, who serves as the Chief Executive Officer of the company, sold 6,928 shares for $52.80 each. As a result, the insider received 365,798 and left with 189,973 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 102.33 while its Price-to-Book (P/B) ratio in mrq is 1.98.
Stock Price History:
Over the past 52 weeks, CRSP has reached a high of $90.62, while it has fallen to a 52-week low of $36.52. The 50-Day Moving Average of the stock is 4.56%, while the 200-Day Moving Average is calculated to be -9.80%.
Shares Statistics:
A total of 85.74M shares are outstanding, with a floating share count of 82.08M. Insiders hold about 4.31% of the company’s shares, while institutions hold 69.42% stake in the company.
